(Report ID: 174001) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,579 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 136 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 174001 | Jul, 30, 2006 | 74 | Female |
List of drugs the patient takes:
Results from eHealthMe: 136 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Hyphaema | 4 (2.94%) |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Toxic Anterior Segment Syndrome | 2 (50.00%) |
2 | Nausea | 1 (25.00%) |
3 | Muscular Weakness | 1 (25.00%) |
4 | Dyspnoea | 1 (25.00%) |
5 | Post Procedural Complication | 1 (25.00%) |
6 | Gastrointestinal Disorder | 1 (25.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Lidocaine | 2 |
2 | Betadine Ophthalmic | 2 |
3 | Timoptic | 2 |
4 | Diamox | 1 |
5 | Remifentanil | 1 |
6 | Versed | 1 |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Iritis | 31 (22.79%) |
2 | Macular Oedema | 31 (22.79%) |
3 | Corneal Opacity | 21 (15.44%) |
4 | Corneal Oedema | 17 (12.50%) |
5 | Eye Inflammation | 13 (9.56%) |
6 | Visual Acuity Reduced | 11 (8.09%) |
7 | Electrocardiogram St Segment Elevation | 9 (6.62%) |
8 | Eye Disorder | 9 (6.62%) |
9 | Uveitis | 9 (6.62%) |
10 | Inflammation | 8 (5.88%) |
| Name | Count |
1 | Cefazolin | 31 |
2 | Decadron | 28 |
3 | Xylocaine | 13 |
4 | Lidocaine | 9 |
5 | Tropicamide | 9 |
6 | Zymar | 8 |
7 | Isosorbide Dinitrate | 7 |
8 | Alphagan | 7 |
9 | Dobutamine Hcl | 6 |
10 | Cyclopentolate Hydrochloride | 5 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
